Scientific Reports (May 2023)

The medicinal activity of lyophilized aqueous seed extract of Lepidium sativum L. in an androgenic alopecia model

  • Marzough Aziz Albalawi,
  • Ahmed M. Hafez,
  • Seham S. Elhawary,
  • Nada K. Sedky,
  • Omnia F. Hassan,
  • Rofanda M. Bakeer,
  • Soha Abd El Hadi,
  • Ahmed H. El-Desoky,
  • Sebaey Mahgoub,
  • Fatma A. Mokhtar

DOI
https://doi.org/10.1038/s41598-023-33988-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Abstract This study evaluated the topical effect of Lepidium sativum lyophilized seed extract (LSLE) towards Sustanon-induced alopecia in male adult Wistar albino rats in vivo, compared to minoxidil topical reference standard drug (MRD). LC–MS/MS together with molecular networking was used to profile the metabolites of LSLE. LSLE treated group revealed significant changes in alopecia related biomarkers, perturbation of androgenic markers; decline in testosterone level and elevation in 5α-reductase (5-AR); decline in the cholesterol level. On the other hand, LSLE treated group showed improvement in vascular markers; CTGF, FGF and VEGF. Groups treated topically with minoxidil and LSLE showed significant improvement in hair length. LC–MS/MS profile of LSLE tentatively identified 17 constituents: mainly glucosinolates, flavonoid glycosides, alkaloids and phenolic acids. The results point to the potential role of LSLE in the treatment of alopecia through decreasing 5(alpha)-dihydrotestosterone levels. Molecular docking was attempted to evaluate the probable binding mode of identified compounds to androgen receptor (PDB code: 4K7A).